Adare Pharma Solutions specializes in developing innovative oral dosage forms through a range of advanced technologies aimed at addressing complex pharmaceutical challenges. Their technology platforms focus on taste masking, controlled release, and solubility enhancement, which are critical for improving patient adherence and therapeutic efficacy. Notable technologies include AdvaTab®, which offers an orally disintegrating tablet solution that masks unpleasant tastes, and Diffutab®, designed for targeted drug delivery with sustained release profiles. Additionally, their solubility enhancement platform utilizes proprietary activation systems to improve drug absorption and bioavailability, making it particularly beneficial for poorly soluble compounds.

The company also emphasizes patient-centric solutions, providing customized drug release profiles and formulations tailored to specific patient needs, including pediatric and geriatric populations. Their innovative delivery systems, such as the Optimμm® microcapsules and Parvulet® technology, enhance the overall patient experience by ensuring accurate dosing and improving the onset of action. With a proven track record of developing over 65 products for global markets, Adare Pharma Solutions is committed to transforming drug delivery and improving patient outcomes through their specialized technologies and comprehensive manufacturing capabilities.

United States

Adare Pharma Solutions is a global technology-driven CDMO providing end-to-end integrated services, from product development through commercial manufacturing and packaging, with expertise focusing on oral dosage forms for the Pharmaceutical industry. Adare's specialized technology platforms provide taste masking, controlled release, solubility enhancement, and patient-centric dosing solutions. With a proven history in drug delivery, Adare has developed and manufactures more than 45 products sold by customers worldwide.

Adare Pharma Solutions

Company Details